Generic Medicine Info
Indications and Dosage
Allergic rhinitis, Asthma
Adult: 225 mg bid.
Child: 3.5 mg/kg bid. Max dose: 10 mg/kg/day (not exceeding 450 mg daily).
Acute asthma attacks; hepatic impairment/cirrhosis.
Special Precautions
Renal impairment. Possible elevations in liver enzymes. Withdraw treatment in patients showing signs consistent with Churg-Strauss syndrome.
Adverse Reactions
Headache, increased incidence of resp tract infection, GI disturbances, induced generalised pain, fever, myalgia, arthralgia.
Drug Interactions
Concurrent use with warfarin and other anticoagulants may cause an increase in prothrombin time.
Description: Pranlukast is a selective leukotriene D4-receptor antagonist. It suppresses early and late bronchoconstrictor responses to inhaled antigen or irritants.
MIMS Class
Antiasthmatic & COPD Preparations
Disclaimer: This information is independently developed by MIMS based on Pranlukast from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2022 MIMS. All rights reserved. Powered by
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in